Four cases of clinical Stage I endometrial carcinoma initially treated with
hormonal therapy are included in this study. Three of them resulted in tum
or regression and two of them permitted a subsequent three pregnancies. All
patients are alive and without evidence of disease with a median follow-up
of 35.7 months (range 17 to 72 months).
We believe this is a promising approach through which we may be able to off
er a conservative treatment maintaining high survival rates and preserving
childbearing potential. Diagnostic and therapeutic data for fertility-desir
ing patients with endometrial carcinoma are analyzed in this study.